Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity Intervention (PREDICOP)
Sponsor: Institut Català d'Oncologia
Listed as NCT02035631, this PHASE3 trial focuses on Breast Neoplasms and Recurrence and remains ongoing. Sponsored by Institut Català d'Oncologia, it has been updated 7 times since 2014, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Mar 2022 — Jul 2024 [monthly]
Unknown Status PHASE3
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Mar 2022 [monthly]
Not Yet Recruiting PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Not Yet Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institut Català d'Oncologia
For direct contact, visit the study record on ClinicalTrials.gov .